11.76 USD
▼-0.59-4.78%
盘后 14.27 0.00%
2026-09-15
市值
$715.71M
市盈率
—
EPS
-0.60
股息率
—
52 周区间
8.86 – 26.19
成交量
175.07K
Beta
-0.23
目标价
41.41
52W 低 8.8652W 高 26.19
价格走势
公司简介
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs include celiac disease. ...